These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2173355)

  • 21. On the role of neuropeptide Y in information handling in the central nervous system in normal and physiopathological states. Focus on volume transmission and neuropeptide Y/alpha 2 receptor interactions.
    Fuxe K; Agnati LF; Härfstrand A; Zoli M; von Euler G; Grimaldi R; Merlo Pich E; Bjelke B; Eneroth P; Benfenati F
    Ann N Y Acad Sci; 1990; 579():28-67. PubMed ID: 2159745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sympathetic co-transmission: the coordinated action of ATP and noradrenaline and their modulation by neuropeptide Y in human vascular neuroeffector junctions.
    Pablo Huidobro-Toro J; Verónica Donoso M
    Eur J Pharmacol; 2004 Oct; 500(1-3):27-35. PubMed ID: 15464018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues.
    Dumont Y; Martel JC; Fournier A; St-Pierre S; Quirion R
    Prog Neurobiol; 1992; 38(2):125-67. PubMed ID: 1312243
    [No Abstract]   [Full Text] [Related]  

  • 24. [The role of neuropeptide Y in anxiety].
    Krysiak R; Obuchowicz E; Herman ZS
    Psychiatr Pol; 2001; 35(5):731-42. PubMed ID: 11842605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
    Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
    Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropeptide Y and its receptors as potential therapeutic drug targets.
    Silva AP; Cavadas C; Grouzmann E
    Clin Chim Acta; 2002 Dec; 326(1-2):3-25. PubMed ID: 12417094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of neuropeptide Y and Y1 receptor in antinociception in the arcuate nucleus of hypothalamus, an immunohistochemical and pharmacological study in intact rats and rats with inflammation.
    Li JJ; Zhou X; Yu LC
    Pain; 2005 Nov; 118(1-2):232-42. PubMed ID: 16216414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
    Kotagale NR; Paliwal NP; Aglawe MM; Umekar MJ; Taksande BG
    Peptides; 2013 Sep; 47():7-11. PubMed ID: 23816796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of hypothalamic neuropeptide Y in feeding and obesity.
    Gehlert DR
    Neuropeptides; 1999 Oct; 33(5):329-38. PubMed ID: 10657510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Leu31, Pro34] NPY, a selective functional postjunctional agonist at neuropeptide-Y receptors in anaesthetised rats.
    Potter EK; McCloskey MJ
    Neurosci Lett; 1992 Jan; 134(2):183-6. PubMed ID: 1317023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the neuropeptide Y receptor in the rat brain and intestine.
    Taylor IL; Mannon PJ; Heintz GG; Kaiser LM; Nguyen TD
    Ann N Y Acad Sci; 1990; 611():48-57. PubMed ID: 2174223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurobiology and clinical aspects of neuropeptide Y.
    Heilig M; Widerlöv E
    Crit Rev Neurobiol; 1995; 9(2-3):115-36. PubMed ID: 8581979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine control of feeding behavior and psychomotor activity by neuropeptideY in fish.
    Matsuda K; Sakashita A; Yokobori E; Azuma M
    Neuropeptides; 2012 Dec; 46(6):275-83. PubMed ID: 23122775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-function analysis of stimulation of food intake by neuropeptide Y: effects of receptor agonists.
    Kalra SP; Dube MG; Fournier A; Kalra PS
    Physiol Behav; 1991 Jul; 50(1):5-9. PubMed ID: 1658831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central control of feeding behavior by neuropeptide Y.
    Zimanyi IA; Fathi Z; Poindexter GS
    Curr Pharm Des; 1998 Aug; 4(4):349-66. PubMed ID: 10197048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs?
    Obuchowicz E; Krysiak R; Herman ZS
    Neurosci Biobehav Rev; 2004 Oct; 28(6):595-610. PubMed ID: 15527865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropeptide Y and its Involvement in Chronic Pain.
    Diaz-delCastillo M; Woldbye DPD; Heegaard AM
    Neuroscience; 2018 Sep; 387():162-169. PubMed ID: 28890052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothalamic circuitry of neuropeptide Y regulation of neuroendocrine function and food intake via the Y5 receptor subtype.
    Campbell RE; ffrench-Mullen JM; Cowley MA; Smith MS; Grove KL
    Neuroendocrinology; 2001 Aug; 74(2):106-19. PubMed ID: 11474218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central neuropeptide Y in anxiety- and stress-related behavior and in ethanol intake.
    Thorsell A
    Ann N Y Acad Sci; 2008 Dec; 1148():136-40. PubMed ID: 19120101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of NPY Y2 receptor protein expression in the mouse brain. II. Coexistence with NPY, the Y1 receptor, and other neurotransmitter-related molecules.
    Stanić D; Mulder J; Watanabe M; Hökfelt T
    J Comp Neurol; 2011 May; 519(7):1219-57. PubMed ID: 21452195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.